Skip to content

Drug interactions

Darunavir + Linagliptin

Severity: Minor

Darunavir and Linagliptin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Boosted darunavir inhibits CYP3A4 and P-gp, which may raise linagliptin levels, though this is rarely significant. Antiretroviral therapy may also worsen insulin resistance and hyperglycemia.

What this interaction means in plain words

Darunavir and Linagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Darunavir belongs to Anti Virals; Linagliptin belongs to Endocrine.

Evidence level: Low

Why it happens

CYP3A4/P-gp inhibition by darunavir raises linagliptin exposure; protease inhibitors may also cause insulin resistance.

What to do

No linagliptin dose change needed; monitor glucose and HbA1c during antiretroviral therapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Darunavir and Linagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Darunavir with Linagliptin?

MediHelp rates the interaction as minor. Darunavir and Linagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Boosted darunavir inhibits CYP3A4 and P-gp, which may raise linagliptin levels, though this is rarely significant. Antiretroviral therapy may also worsen insulin resistance and hyperglycemia.

How serious is the interaction between Darunavir and Linagliptin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No linagliptin dose change needed; monitor glucose and HbA1c during antiretroviral therapy.

What other medicines interact with Linagliptin?

MediHelp also lists interactions of Linagliptin with, for example, Alogliptin-pioglitazone, Amlodipine-benazepril, Amobarbital. The full list is on the Linagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in